Go to Sitemap
Search SickKids
Going ‘outside the box’ to explain different symptoms in people with the same DNA deletion syndrome
November 9, 2020
Even when genetic conditions can be clearly traced to a root cause in the DNA, how those conditions present can vary. A team from the International 22q11.2 Deletion Syndrome Brain Behavior Consortium (IBBC), led by SickKids, discovered they needed …
January 27, 2022
Immune checkpoint inhibitors may help treat some childhood cancers that are resistant to more common cancer treatments such as chemotherapy and radiation therapy.
November 25, 2021
Researchers have identified for the first time a potential biomarker that could be used as a predictive tool in the care of children with CFSPID, an inconclusive cystic fibrosis diagnosis.
SickKids study finds speed limit reduction made Toronto roads safer for pedestrians
February 10, 2020
A unique study design by SickKids researchers is one of few in the world to compare effects of speed limit reduction before and after implementation.
SickKids researchers awarded $7.5 million for microbiome and immunology research
February 7, 2020
Researchers from SickKids recently received $7.5 million in funding to study the microbiome and immunology. These team grants were awarded by CIHR and partners in the Canadian Microbiome Initiative 2 and Human Immunology Initiative competitions.
A promising new treatment for recurrent paediatric brain cancer
April 27, 2020
A multi-institutional, international team has developed a novel approach that delivers CAR T cell therapy directly into the cerebrospinal fluid that surrounds a brain tumour.
SickKids researchers re-engineer toxin to attack previously “undruggable” cancer target
July 10, 2020
Researchers have developed a novel anti-cancer drug protein, which could lead to the development of future therapies for what was previously considered an “undruggable” target.
SickKids scientist Dr. Jean-Philippe Julien named one of Canada’s Top 40 Under 40
November 18, 2021
Dr. Jean-Philippe Julien is one of Canada’s Top 40 Under 40® for 2021, recognized for his contributions to antibody research and commitment to research translation.
Promising new approach to stop growth of brain cancer cells
February 12, 2021
Researchers at SickKids, Princess Margaret Cancer Centre and University of Toronto, showed that chemically inhibiting the enzyme PRMT5 can suppress the growth of glioblastoma cells.
New research reveals impact of COVID-19 pandemic on child and youth mental health
February 26, 2021
SickKids-led study shows troubling impact of COVID-19 pandemic on child and youth mental health.
